1. Home
  2. Healthcare

Global Skin Grafting Market Size, Share, Opportunities, And Trends By Graft Type (Autologous, Allogenic, Xenogenic, Prosthetic), By Graft Thickness (Slip Thickness, Full Thickness, Composite Graft), By Application (Extensive Wounds, Burns, Extensive Skin Loss Due To Infection, Skin Cancers, Others), By Equipment (Dermatome, General Surgical Instruments, Consumables, Others), By End Users (Hospitals And Clinics, Academic And Research, Others) And By Geography - Forecasts From 2019 To 2024.

Published:  May 2020 Report Code: KSI061611140 Pages: 114    

The Global Skin Grafting Market is projected to witness a compound annual growth rate of 12.29% during the forecast period to reach a total market size of US$6.825 billion by 2023, increasing from US$3.824 billion in 2018. The increasing numbers of burn injuries, skin infections, and ulcer pressure are leading to prolonged hospitalization and medical condition requiring immediate attention. The development of skin grafting techniques and technological advances in dermatomes are some of the factor boosting the global skin grafting market.

Geographically, North America is projected to continue to lead the global skin grafting market due to the high adoption rate of new technology and greater purchasing power relative to other regions. However, according to WHO, a majority of the burn cases are found in South East Asia region and thus this represents the untapped potential of the market.

Competitive Landscape

The Global Skin Grafting Market is competitive owing to them to the presence of well-diversified international, regional and local players. However, some big international players dominate the market share owing to their brand image and market reach. The high market growth and favorable government policies are further attracting more players in the market while enhancing the competitive rivalry. The competitive landscape details strategies, products, and investments being done by key players in different technologies and companies to boost their market presence.

Some of the major players discussed in the report are Organogenesis, Inc., Exsurco Medical, Inc., Mallinckrodt Pharmaceuticals, Tissue Regenix, Avita Medical among others.

Segmentation

The Global Skin Grafting Market has been segmented by graft type, graft thickness, application, equipment, end users, and geography.

By Graft Type

Autologous

Allogenic

Xenogenic

Prosthetic

 

By Graft Thickness

Slip Thickness

Full Thickness

Composite Graft

 

By Application

Extensive Wounds

Burns

Extensive skin loss due to infection

Skin Cancers

Others

 

By Equipment

Dermatome

General Surgical Instruments

Consumables

Others

 

By End Users

Hospitals and Clinics

Academic and Research

Others

 

By Geography

Americas

North America

South America

Europe Middle East and Africa

Europe

MEA

Asia Pacific

Frequently Asked Questions (FAQs)

Q1. What are the growth prospects for skin grafting market?
A1. The global skin grafting market is projected to witness a CAGR of 12.29% during the forecast period.
 
Q2. What will be the skin grafting market size by 2023?
A2. The skin grafting market is projected to reach a total market size of US$6.825 billion by 2023.
 
Q3. What is the size of global skin grafting market?
A3. Skin Grafting market was valued at US$3.824 billion in 2018. 
 
Q4. What factors are anticipated to drive the skin grafting market growth?
A4. The development of skin grafting techniques and technological advances in dermatomes are some of the factors boosting the global skin grafting market.
 
Q5. Which region holds the largest market share in the skin grafting market?
A5. Geographically, North America is projected to continue to lead the global skin grafting market due to the high adoption rate of new technology and greater purchasing power relative to other regions.
1. Introduction
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. Research Methodology
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. Key Findings Of The Study
4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. Global Skin Grafting Market Forecast By Type (US$ billion)
5.1. Introduction
5.2. Autologous
5.3. Allogenic
5.4. Xenogenic
5.5. Prosthetic
6. Global Skin Grafting Market Forecast By Thickness (US$ billion)
6.1. Introduction
6.2. Split Thickness
6.3. Full Thickness
6.4. Composite Graft
7. Global Skin Grafting Market Forecast By Application (US$ billion)
7.1. Introduction
7.2. Extensive Wounds
7.3. Burns
7.4. Extensive Skin Loss Due To Infection
7.5. Skin Cancers
7.6. Others
8. Global Skin Grafting Market Forecast By Equipment (US$ billion)
8.1. Introduction
8.2. Dermatome
8.3. General Surgical Instruments
8.4. Consumables
8.5. Others
9. Global Skin Grafting Market Forecast By End User (US$ billion)
9.1. Introduction
9.2. Hospital and Clinics
9.3. Academic and Research
9.4. Others
10. Global Skin Grafting Market Forecast By Geography (US$ billion)
10.1. Introduction
10.2. Americas
10.2.1. North America
10.2.2. South America
10.3. Europe and MEA
10.3.1. Europe
10.3.2. Middle East And Africa (MEA)
10.4. Asia Pacific 
11. Competitive intelligence
11.1. Investment Analysis
11.2. Strategies of Key Players
11.3. Recent Investments And Deals
12. Company profiles
12.1. Organogenesis Inc.
12.1.1. Overview
12.1.2. Financials
12.1.3. Product and Services
12.1.4. Key Developments
12.2. Exsurco Medical, Inc.
12.2.1. Overview
12.2.2. Financials
12.2.3. Products and Services
12.2.4. Key Developments
12.3. Mallinckrodt Pharmaceuticals
12.3.1. Overview
12.3.2. Financials
12.3.3. Products and Services
12.3.4. Key Developments
12.4. Tissue Regenix Group
12.4.1. Overview
12.4.2. Financials
12.4.3. Products and Services
12.4.4. Key Developments
12.5. Avita Medical 
12.5.1. Overview
12.5.2. Financials
12.5.3. Products and Services
12.5.4. Key Developments
12.6. Zimmer Biomet
12.6.1. Overview
12.6.2. Financials
12.6.3. Products and Services
12.6.4. Key Developments
12.7. Aesculap, Inc
12.7.1. Overview
12.7.2. Financials
12.7.3. Products and Services
12.7.4. Key Developments
12.8. Nouvag AG
12.8.1. Overview
12.8.2. Financials
12.8.3. Products and Services
12.8.4. Key Developments
12.9. Surtex Instruments limited
12.9.1. Overview
12.9.2. Financials
12.9.3. Products and Services
12.9.4. Key Developments
Organogenesis Inc.
Exsurco Medical, Inc.
Mallinckrodt Pharmaceuticals
Tissue Regenix Group
Avita Medical 
Zimmer Biomet
Aesculap, Inc
Nouvag AG
Surtex Instruments limited

Pricing

Explore Custom Options available with this study:

  •  Request customization
  •  Buy sections of the study
  •  Buy country specific report
  •  Request excel, Historical data
  •  Subscription inquiry
  •  Request special pricing

Our Value Proposition

Analyst Support

All our studies come with 2 months of analyst support.

Confidentiality

We are in compliance with the global privacy laws.

 

Connect With Us

 

Related Reports